Multidisciplinary Inpatient Palliative Care Intervention

Sponsor

Kaiser Permanente (Other)

Overall Status

Completed

CT.gov ID

NCT00325611

Collaborator

Garfield Memorial Fund (Other)

550

Enrollment

Location

Duration (Months)

20.4

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Palliative care is believed to improve care of patients with life-limiting illnesses. This study evaluated the impact of a multi-center randomized trial of a palliative care team intervention on the quality and cost of care of hospitalized patients. Study subjects were randomized to intervention or usual care. At study end, patients receiving the palliative care intervention reported greater patient satisfaction with their care. Intervention patients also had significantly fewer ICU admissions and lower total costs for care 6 months past their hospitalization. Intervention patients completed more advance directives and had longer hospice stays.

Condition or Disease	Intervention/Treatment	Phase
Cerebrovascular Accident Cancer Coronary Arteriosclerosis Heart Failure, Congestive Diabetes Mellitus Acquired Immunodeficiency Syndrome Failure to Thrive Pulmonary Disease, Chronic Obstructive Dementia Kidney Failure, Chronic Pneumonia Liver Failure Renal Failure Respiratory Failure Stroke	Behavioral: Multidisciplinary palliative care team met with patient	N/A

Detailed Description

The Inpatient Palliative Care Service (IPCS) was implemented at three Kaiser-Permanente sites: Colorado, Portland and San Francisco. The service consisted of a physician, nurse, social worker, and spiritual counselor who worked with the study subjects randomized to receive the intervention. The intervention included symptom control, emotional and spiritual support, advance care and post-discharge care planning, There were no differences in symptom control or emotional support but IPCS patient reported better spiritual support compared to usual care patients. IPCS patients also reported greater satisfaction with their hospital care experience and better communication with their providers. Both IPCS and usual care patients reported improved quality of life during their enrollment hospital stay. IPCS patients completed more advance directives. IPCS patients had more home health visits than usual care patients but significantly fewer ICU admissions. IPCS patients had significantly lower hospital costs and higher pharmacy costs, than the usual care patients. IPCS patients had significantly lower (p= .001) total health services costs (a cost savings of $64.90 per patient per day) compared to usual care patients. This translated to an average total cost savings of $3,185 per enrolled patient. IPCS patients had a significantly longer average hospice length of stay. There were no differences between IPC and usual care patients in the proportion admitted to hospice, time to hospice admission, the average length of survival, or proportion of those who survived to 6 months.

Conclusion: IPCS resulted in better spiritual support, a better hospital care experience, better communication with their providers, increased completion of advance directives, fewer ICU admissions, longer hospice stays and reduced overall health care costs.

Study Design

Study Type:

Interventional

Allocation:

Randomized

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Prevention

Official Title:

A Multi-Site Replication of an Inpatient Palliative Care Program

Study Start Date :

Apr 1, 2002

Study Completion Date :

Jul 1, 2004

Outcome Measures

Primary Outcome Measures

Quality and cost of care []

Secondary Outcome Measures

Greater patient satisfaction []
Lower ICU admissions []
Lower total costs 6 months past hospitalization []

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Adults 18 years and older

-admitted to acute inpatient care who had: (1) a medical diagnosis which was life-threatening, and (2) whose attending physician indicated they "would not be surprised if the patient died within one year".

Exclusion Criteria:

1. they had impaired cognitive status and no caregiver was available to provide consent, (2) were currently enrolled in hospice or other studies involving palliative care, (3) the attending physician did not approve study participation, or (4) their medical condition impaired participation (actively dying, too ill to participate) and no family member was available to provide consent.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Kaiser Permanente of Colorado	Aurora	Colorado	United States	80014

Sponsors and Collaborators

Kaiser Permanente
Garfield Memorial Fund

Investigators

Study Director: Ingrid M Venohr, RN, PhD, Kaiser Permanente
Principal Investigator: Douglas A Conner, PhD, Kaiser Permanente Northwest Region
Principal Investigator: Marcia Liberson, MSW,MPH, Kaiser-Permanente Northwest Region